Home

Intelligence

Services

Subscriptions

News

About Us

Sign In

 

Document Preview

Nonexclusive Sublicense Agreement

 

Click "Add to Cart" button to purchase document. 
Documents are emailed immediately after purchase. 
You can also browse documents by
title, category, or company... or click here for help finding documents.

 

Title:

Nonexclusive Sublicense Agreement

Entities:

First Horizon Pharmaceutical Corp.; Pharmaceutical Formulations Inc.; Jame Fine Chemicals Inc.

Date:

2002

Size:

Preview shows 5KB of 16KB total

Price:

$37

ID:

#151441

 

 

► Licensing ► Licenses ► Sublicenses ► Non-Exclusive Sublicense Agreements
► Biotechnology & Drugs
► Biotech & Drugs ► Pharmaceutical Preparations

 

 

Start of Preview




NONEXCLUSIVE SUBLICENSE AGREEMENT

THIS AGREEMENT, entered into this 27th day of June, 2002 by and between
First Horizon Pharmaceutical Corporation, a corporation of the State of Delaware
having its principal address at 6195 Shiloh Road, Alpharetta, Georgia 30005
(hereinafter referred to as "FHRX") and Jame Fine Chemicals Inc. (d/b/a JFC
Technologies), a corporation of the State of New Jersey having its principal
address at 100 West Main Street, P.O. Box 669, Bound Brook, New Jersey 08805
(hereinafter referred to as "JFC");

WITNESSETH THAT:

WHEREAS, JFC is a manufacturer of bulk active ingredients useful in the
preparation of pharmaceutical formulations;

WHEREAS, JFC is a manufacturer of dextromethorphan tannate and
dexchlorpheniramine tannate (hereinafter collectively referred to as "Licensed
Products");

WHEREAS, JFC has developed, over a considerable period of time and at
considerable monetary expense, a body of technical information (hereinafter
being defined and referred to as "JFC's Technical Information") relating to the
manufacture and use of Licensed Products;

WHEREAS, JFC has developed, over a considerable period of time and at
considerable monetary expense, United States patent applications covering the
manufacturer, use and sale of Licensed Products, and JFC anticipates filing
further United States patent applications (hereinafter being defined and
referred to as "JFC's Patent Rights") covering the manufacturer, use and sale of
Licensed Products (hereinafter being defined and referred to as "JFC's Patent
Rights");

Page 1 of 8
{PAGE}


WHEREAS, FHRX is a specialty pharmaceutical company which markets,
distributes and sells pharmaceutical formulations;

WHEREAS, Unisource Corporation, a corporation of the State of Colorado
having a principal address at 4300 Sunshine Avenue, Boulder, Colorado 80302
(hereinafter referred to as "UNISOURCE") manufactures, markets, sells and
distributes pharmaceutical formulations;

WHEREAS, pursuant to a certain "Exclusive License Agreement" of even date,
JFC granted FHRX an exclusive license and right under JFC's Technical
Information and Patent Rights to make, have made, use, distribute, market,
promote, advertise and sell Licensed Products and to make, have made, use,
distribute, market, promote, advertise and sell pharmaceutical formulations
containing Licensed Products (such pharmaceutical formulations hereinafter being
defined and referred to as "Finished Dosage Products");

WHEREAS, pursuant to Paragraph 2.02 of said Exclusive License Agreement,
the parties provided that FHRX would grant a sublicense to JFC under JFC's
Patent Rights and JFC's Technical Information to manufacture Licensed Products;

WHEREAS, JFC has entered into certain prior supply agreements with
UNISOURCE (hereinafter referred to as "Existing JFC-UNISOURCE Agreements")
whereby UNISOURCE purchases bulk active ingredients useful in the preparation of
pharmaceutical formulations from JFC;

WHEREAS, FHRX has entered into certain prior supply agreements with
UNISOURCE (hereinafter referred to as "Existing FHRX-UNISOURCE Agreements")
whereby FHRX purchases pharmaceutical formulations from UNISOURCE;

WHEREAS, FHRX and UNISOURCE have entered into a new supply agreement
(hereinafter referred to as "New FHRX-UNISOURCE Agreement") whereby UNISOURCE
will supply FHRX with Finished Dosage Products;



Page 2 of 8
{PAGE}

WHEREAS, on even date with entry into this Agreement and the License
Agreement, JFC will enter into a new agreement or agreements with Unisource
("New JFC-Unisource Agreement");

WHEREAS, in order to effectuate the commercialization of Finished Dosage
Products, FHRX wishes to have JFC manufacture Licensed Products and ship such
Licensed Products exclusively to FHRX's designated supplier(s) (currently
UNISOURCE) and JFC is willing to manufacture Licensed Products and ship such
Licensed Products exclusively to FHRX's designated supplier(s);

NOW, THEREFORE, in consideration of the foregoing premises, promises and
the mutual covenants hereinafter recited and other good and valuable

 

End of Preview

 

Home        Intelligence        Services        Subscriptions        News        About Us

Contact Us       Terms of Use       Resend Documents       Shopping Cart

Copyright © 2008 The Consus Group LLC